Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced it will report first quarter 2014 financial results on Thursday, May 15, 2014. Eleven’s management team will host a conference call and audio webcast at 8:30 a.m., Eastern Time on Thursday, May 15, 2014 to discuss the quarterly results and recent business developments.
Help employers find you! Check out all the jobs and post your resume.
